Rendering
| Component: (Network and Table) |
|---|
| Network | 2313301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) (http://www.agilent.com/role/GoodwillAndOtherIntangibleAssetsTables) |
| Table | (Implied) |
Slicers (applies to each fact value in each table cell)
| Reporting Entity [Axis] | 0001090872 (http://www.sec.gov/CIK) |
| Goodwill and Intangible Assets Disclosure [Abstract] | Period [Axis] |
|---|
2015-11-01 - 2016-10-31 |
|---|
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill balances and movements for each reportable segments during the period | The goodwill balances at October 31, 2016, 2015 and 2014 and the movements in 2016 and 2015 for each of our reportable segments are shown in the table below:
| | | | | | | | | | | | | | | | | | Life Sciences and Applied Markets | | Diagnostics and Genomics | | Agilent CrossLab | | Total | | (in millions) | Goodwill as of October 31, 2014 | $ | 668 |
| | $ | 1,345 |
| | $ | 494 |
| | $ | 2,507 |
| Foreign currency translation impact | (18 | ) | | (166 | ) | | (12 | ) | | (196 | ) | Goodwill arising from acquisitions | — |
| | 55 |
| | — |
| | 55 |
| Goodwill as of October 31, 2015 | $ | 650 |
| | $ | 1,234 |
| | $ | 482 |
| | $ | 2,366 |
| Foreign currency translation impact | 3 |
| | (11 | ) | | 3 |
| | (5 | ) | Goodwill arising from acquisitions | 137 |
| | — |
| | 19 |
| | 156 |
| Goodwill as of October 31, 2016 | $ | 790 |
| | $ | 1,223 |
| | $ | 504 |
| | $ | 2,517 |
|
|
Components of other intangibles during the period | The component parts of other intangible assets at October 31, 2016 and 2015 are shown in the table below: | | | | | | | | | | | | | | Other Intangible Assets | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Book Value | | (in millions) | As of October 31, 2015: | | | | | | Purchased technology | $ | 746 |
| | $ | 476 |
| | $ | 270 |
| Trademark/Tradename | 141 |
| | 50 |
| | 91 |
| Customer relationships | 230 |
| | 168 |
| | 62 |
| Total amortizable intangible assets | $ | 1,117 |
| | $ | 694 |
| | $ | 423 |
| In-Process R&D | 22 |
| | — |
| | 22 |
| Total | $ | 1,139 |
| | $ | 694 |
| | $ | 445 |
| As of October 31, 2016: | | | | | | Purchased technology | $ | 823 |
| | $ | 572 |
| | $ | 251 |
| Backlog | 1 |
| | 1 |
| | — |
| Trademark/Tradename | 149 |
| | 61 |
| | 88 |
| Customer relationships | 263 |
| | 211 |
| | 52 |
| Total amortizable intangible assets | $ | 1,236 |
| | $ | 845 |
| | $ | 391 |
| In-Process R&D | 17 |
| | — |
| | 17 |
| Total | $ | 1,253 |
| | $ | 845 |
| | $ | 408 |
|
|
Future Amortization expense for the next five years and thereafter | Future amortization expense related to existing finite-lived purchased intangible assets for the next five fiscal years and thereafter is estimated below: | | | | | Estimated future amortization expense: | | (in millions) | | 2017 | $ | 112 |
| 2018 | $ | 82 |
| 2019 | $ | 58 |
| 2020 | $ | 47 |
| 2021 | $ | 35 |
| Thereafter | $ | 57 |
|
|